Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-22-005327

Chief Financial Officer sold 1,347 shares at $4.33 ($5,834)

  • Chief Financial Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

PFREUNDSCHUH PETER P. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-14 Exercise or conversion : show line 1 in the form +15,000 15,745 D
2022-02-15 Sale : show line 2 in the form −1,347 $4.33 $5,834 14,398 D
Open-market sales · 1,347 sh · avg $4.33 · $5,834

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2022-02-14 Exercise or conversion : show line 3 in the form Restricted Stock Unit −15,000 15,000 15,000 D
Loading xslF345X03/form4.xml…